XTX Topco’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $174K | Sell |
27,237
-58,575
| -68% | -$374K | 0.01% | 1752 |
|
2025
Q1 | $417K | Buy |
+85,812
| New | +$417K | 0.02% | 1159 |
|
2024
Q3 | – | Sell |
-62,764
| Closed | -$428K | – | 2202 |
|
2024
Q2 | $428K | Buy |
62,764
+43,028
| +218% | +$293K | 0.04% | 736 |
|
2024
Q1 | $49.9K | Buy |
+19,736
| New | +$49.9K | 0.01% | 1475 |
|
2023
Q4 | – | Sell |
-31,462
| Closed | -$107K | – | 1716 |
|
2023
Q3 | $107K | Buy |
31,462
+17,636
| +128% | +$60K | 0.02% | 1175 |
|
2023
Q2 | $102K | Buy |
+13,826
| New | +$102K | 0.02% | 1163 |
|
2023
Q1 | – | Sell |
-15,307
| Closed | -$181K | – | 1375 |
|
2022
Q4 | $181K | Buy |
+15,307
| New | +$181K | 0.04% | 882 |
|
2021
Q2 | – | Sell |
-4,840
| Closed | -$450K | – | 871 |
|
2021
Q1 | $450K | Buy |
+4,840
| New | +$450K | 0.22% | 126 |
|